Enovis Corporation
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
- 2022-04-05$25.75
Enovis Corporation is a medical technology company focused on developing clinically differentiated solutions for musculoskeletal health. Enovis Corporation designs, manufactures, and distributes medical devices and services used across the patient care continuum, including injury prevention, rehabilitation, pain management, physical therapy, and reconstructive surgery. Its product portfolio includes orthopedic braces and supports, recovery and rehabilitation technologies, joint replacement implants, and surgical enabling tools that support hip, knee, shoulder, elbow, foot, ankle, and other extremity procedures. The company serves healthcare professionals and patients through two main business segments, Prevention & Recovery and Reconstructive, reflecting its role in both non-surgical treatment and surgical care. Enovis Corporation operates in the orthopedic and broader medical device markets, where it provides solutions intended to improve mobility, restore function, and support clinical workflows across hospitals, outpatient settings, and other care environments.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. Damien McDonald
- Employees
- 7,367
- Headquarters
- Wilmington, DE, United States
- Website
- www.enovis.com